134 related articles for article (PubMed ID: 23233144)
1. [Spanish family with spastic paraplegia and demyelinating polyneuropathy: a disease related with PLP1 null syndrome].
Pardal-Fernandez JM
Rev Neurol; 2012 Dec; 55(12):765. PubMed ID: 23233144
[No Abstract] [Full Text] [Related]
2. Pelizaeus-Merzbacher disease and spastic paraplegia type 2: two faces of myelin loss from mutations in the same gene.
Hudson LD
J Child Neurol; 2003 Sep; 18(9):616-24. PubMed ID: 14572140
[TBL] [Abstract][Full Text] [Related]
3. A case of complicated spastic paraplegia 2 due to a point mutation in the proteolipid protein 1 gene.
Lee ES; Moon HK; Park YH; Garbern J; Hobson GM
J Neurol Sci; 2004 Sep; 224(1-2):83-7. PubMed ID: 15450775
[TBL] [Abstract][Full Text] [Related]
4. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
[TBL] [Abstract][Full Text] [Related]
5. Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders.
Hobson GM; Garbern JY
Semin Neurol; 2012 Feb; 32(1):62-7. PubMed ID: 22422208
[TBL] [Abstract][Full Text] [Related]
6. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
Inoue K
Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the PLP1 gene residue p. Gly198 as the molecular basis of Pelizeaus-Merzbacher phenotype.
Hoffman-Zacharska D; Kmieć T; Poznański J; Jurek M; Bal J
Brain Dev; 2013 Oct; 35(9):877-80. PubMed ID: 23245814
[TBL] [Abstract][Full Text] [Related]
8. Arena syndrome is caused by a missense mutation in PLP1.
Stevenson RE; Tarpey P; May MM; Stratton MR; Schwartz CE
Am J Med Genet A; 2009 May; 149A(5):1081. PubMed ID: 19396823
[No Abstract] [Full Text] [Related]
9. Position effect on PLP1 may cause a subset of Pelizaeus-Merzbacher disease symptoms.
Muncke N; Wogatzky BS; Breuning M; Sistermans EA; Endris V; Ross M; Vetrie D; Catsman-Berrevoets CE; Rappold G
J Med Genet; 2004 Dec; 41(12):e121. PubMed ID: 15591263
[No Abstract] [Full Text] [Related]
10. [Pelizaeus-Merzbacher disease(PMD)/spastic paraplegia 2(SPG2)].
Eto Y
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):536-7. PubMed ID: 11032015
[No Abstract] [Full Text] [Related]
11. A new polymorphism in the proteolipid protein (PLP1) gene and its use for carrier detection of PLP1 gene duplication in Pelizaeus-Merzbacher disease.
Hobson G; Stabley D; Funanage V; Marks H
Hum Mutat; 2001 Feb; 17(2):152. PubMed ID: 11180600
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.
Cailloux F; Gauthier-Barichard F; Mimault C; Isabelle V; Courtois V; Giraud G; Dastugue B; Boespflug-Tanguy O
Eur J Hum Genet; 2000 Nov; 8(11):837-45. PubMed ID: 11093273
[TBL] [Abstract][Full Text] [Related]
13. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.
Lossos A; Elazar N; Lerer I; Schueler-Furman O; Fellig Y; Glick B; Zimmerman BE; Azulay H; Dotan S; Goldberg S; Gomori JM; Ponger P; Newman JP; Marreed H; Steck AJ; Schaeren-Wiemers N; Mor N; Harel M; Geiger T; Eshed-Eisenbach Y; Meiner V; Peles E
Brain; 2015 Sep; 138(Pt 9):2521-36. PubMed ID: 26179919
[TBL] [Abstract][Full Text] [Related]
14. Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.
Sypecka J; Domańska-Janik K
Acta Neurobiol Exp (Wars); 2005; 65(2):221-9. PubMed ID: 15960310
[TBL] [Abstract][Full Text] [Related]
15. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
Woodward KJ
Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in PLP1 causes severe hereditary spastic paraplegia type 2.
Noetzli L; Sanz PG; Brodsky GL; Hinckley JD; Giugni JC; Giannaula RJ; Gonzalez-Alegre P; Di Paola J
Gene; 2014 Jan; 533(1):447-50. PubMed ID: 24103481
[TBL] [Abstract][Full Text] [Related]
17. Partial PLP1 deletion causing X-linked dominant spastic paraplegia type 2.
Matsufuji M; Osaka H; Gotoh L; Shimbo H; Takashima S; Inoue K
Pediatr Neurol; 2013 Dec; 49(6):477-81. PubMed ID: 24095575
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.
Yamamoto-Shimojima K; Imaizumi T; Aoki Y; Inoue K; Kaname T; Okuno Y; Muramatsu H; Kato K; Yamamoto T
J Hum Genet; 2019 Jul; 64(7):665-671. PubMed ID: 31004103
[TBL] [Abstract][Full Text] [Related]
19. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease.
Fattal-Valevski A; DiMaio MS; Hisama FM; Hobson GM; Davis-Williams A; Garbern JY; Mahoney MJ; Kolodny EH; Pastores GM
J Child Neurol; 2009 May; 24(5):618-24. PubMed ID: 19151366
[TBL] [Abstract][Full Text] [Related]
20. Classic Pelizaeus-Merzbacher disease in a girl with an unbalanced chromosomal translocation and functional duplication of PLP1.
Yiu EM; Farrell SA; Soman T
Mov Disord; 2009 Oct; 24(14):2171-2. PubMed ID: 19705472
[No Abstract] [Full Text] [Related]
[Next] [New Search]
